Stay updated on Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page
- Check5 days agoChange DetectedThe history now shows that recruitment has ended ('No longer looking for participants') and logs a new revision (v3.6.0) while removing the prior revision entry (v3.5.5).SummaryDifference0.4%

- Check13 days agoChange DetectedA new release entry, v3.5.5, appears in the record history, replacing v3.5.4. This indicates a background update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's Revision label changed from v3.5.3 to v3.5.4 to reflect a new site release; no other study content or details appear to be modified.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page footer’s software/application revision indicator was updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the history. This is a page-version update rather than a change to trial content or results.SummaryDifference0.1%

- Check106 days agoChange DetectedA new version entry v3.4.3 was added and the previous version v3.4.2 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.